Cargando…
Benzimidazole carbamate induces cytotoxicity in breast cancer cells via two distinct cell death mechanisms
Metastatic breast cancer (mBC) is responsible for >90% of breast cancer-related deaths. Microtubule-targeting agents (MTAs) are the front-line treatment for mBC. However, the effectiveness of MTAs is frequently limited by the primary or acquired resistance. Furthermore, recurrent mBC derived from...
Autores principales: | Graff, Brendan T., Palanivel, Chitra, Jenkins, Christopher B., Baranowska-Kortylewicz, Janina, Yan, Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183037/ https://www.ncbi.nlm.nih.gov/pubmed/37179350 http://dx.doi.org/10.1038/s41420-023-01454-6 |
Ejemplares similares
-
Activation of PDGFr-β Signaling Pathway after Imatinib and Radioimmunotherapy Treatment in Experimental Pancreatic Cancer
por: Abe, Michio, et al.
Publicado: (2011) -
Screening the pandemic response box identified benzimidazole carbamates, Olorofim and ravuconazole as promising drug candidates for the treatment of eumycetoma
por: Lim, Wilson, et al.
Publicado: (2022) -
Performance of Methyl-5-Benzoyl-2-Benzimidazole Carbamate (Mebendazole) as Corrosion Inhibitor for Mild Steel in Dilute Sulphuric Acid
por: Edoziuno, F. O., et al.
Publicado: (2020) -
Programmed Cell Death of Human Skin Fibroblast Induced by Benzimidazole
por: Ravikumar, T., et al.
Publicado: (2001) -
Two isostructural carbamates: the o-tolyl N-(pyridin-3-yl)carbamate and 2-bromophenyl N-(pyridin-3-yl)carbamate monohydrates
por: Mocilac, Pavle, et al.
Publicado: (2015)